Search results for:
Ondine Biomedical announces AIM market listing
Ondine Biomedical announces AIM market listing RNS Number : 5992U 06 December 2021 NOT FOR RELEASE, DISTRIBUTION, PUBLICATION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO OR FROM THE UNITED STATES, AUSTRALIA, JAPAN, THE REPUBLIC OF SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE TO [...]
Schedule One Update – Ondine Biomedical Inc.
Schedule One Update- Ondine Biomedical Inc. RNS Number : 2021U 01 December 2021 ANNOUNCEMENT TO BE MADE BY THE AIM APPLICANT PRIOR TO ADMISSION IN ACCORDANCE WITH RULE 2 OF THE AIM RULES FOR COMPANIES ("AIM RULES") COMPANY NAME: Ondine Biomedical Inc. ("Ondine" or the "Company") COMPANY [...]
Schedule One – Ondine Biomedical Inc.
Schedule One - Ondine Biomedical Inc. RNS Number : 1245T 22 November 2021 ANNOUNCEMENT TO BE MADE BY THE AIM APPLICANT PRIOR TO ADMISSION IN ACCORDANCE WITH RULE 2 OF THE AIM RULES FOR COMPANIES ("AIM RULES") COMPANY NAME: Ondine Biomedical Inc. ("Ondine" or the "Company") COMPANY [...]
Carolyn Cross – Mother, Survivor, and Visionary CEO
Carolyn Cross - Mother, Survivor, and Visionary CEO Exclusive Interview for MOM.CEO LUC CHÉNIER FOUNDER OF DAD.CEO & MOM.CEO Thursday, July 30, 2020 It's not every day that you get to interview someone who has survived a plane crash, is fighting the [...]
Verso Surgery Centre Adds Photodisinfection
Verso Surgery Centre Adds Photodisinfection for Patients and Staff during COVID-19 Verso Surgery Centre, the first surgery centre in Canada to deploy nasal photodisinfection for infection prevention, adds solution amidst COVID-19 Oakville, Ontario, Canada - June 08, 2020 Verso Surgery Centre [...]
Ondine Accelerates COVID-19 Program
Ondine Biomedical Accelerates COVID-19 Program Ondine accelerates testing of nasal Photodisinfection against the SARS-CoV-2 novel coronavirus. Vancouver, British Columbia, Canada - May 21, 2020 Ondine Biomedical Inc. announces that it has secured funding from investors including TELUS Ventures to bring the [...]
Ondine Biomedical President is on Life Science Washington Panel Webinar
Ondine Biomedical President is on Life Science Washington Panel Webinar Nicolas G. Loebel, PhD, Chief Technology Officer and President at Ondine Research Laboratories Inc., will be a panelist on a webinar hosted by Life Science Washington and Product Creation Studio where [...]
Rapid Elimination of Bacterium Causing Flesh-Eating Disease
Ondine Biomedical Demonstrates Rapid Elimination of Bacterium Causing Flesh-Eating Disease Photodisinfection eradicates Streptococcus pyogenes (Group A Strep), bacterium associated with Necrotizing Fasciitis Vancouver, British Columbia, Canada - May 7, 2020 Ondine Biomedical Inc., the global leader in Photodisinfection based therapies for [...]
Ondine Targets Coronavirus Directly with Photodisinfection
Canada’s Ondine Biomedical Targets Coronavirus Directly in Nose and Nasopharynx with Photodisinfection Photodisinfection market leader launches proven antimicrobial technology into COVID-19 battle. Vancouver, British Columbia, Canada - May 5, 2020 Vancouver-based Ondine Biomedical Inc., the global leader in Photodisinfection technology, announces [...]
Ondine Receives CE Mark for its Steriwave Nasal Photodisinfection Therapy
Ondine Biomedical Receives CE Mark for its Steriwave Nasal Photodisinfection Therapy Nasal photodisinfection has helped to significantly reduce healthcare-associated infections in Canadian hospitals and is now approved for use in the European Union Vancouver, British Columbia, Canada - May 4, 2020 [...]
For Media Information
Simon Vane Percy
Amanda Bernard
